Radiant Biotherapeutics

Radiant Biotherapeutics is a biotechnology company based in Toronto, founded in 2020.

The company focuses on developing its proprietary MultabodyTM antibody platform, which creates multi-valent, multi-specific therapeutics aimed at treating challenging diseases, particularly cancer, infectious diseases, and autoimmune/inflammatory conditions. The MultabodyTM platform combines high avidity and multi-specificity in engineered molecules, allowing for the simultaneous engagement of multiple targets or pathways. This innovative approach aims to produce therapeutics that are stronger, more precise, and more durable than traditional antibodies. Radiant Biotherapeutics is advancing a pipeline of mono-, bi-, and tri-specific biologics, with preclinical programs targeting areas such as oncology, COVID-19, and HIV. The company emphasizes its scientific foundation from research at SickKids and the University of Toronto and operates offices in Toronto and Philadelphia.